Medical Devices

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

A manufacturing flaw in some Omnipod 5 insulin pods has caused serious health issues, prompting a company response and raising questions about device safety.

A legislative movement across 11 states aims to make scalp cooling, a therapy to prevent hair loss during chemo, an insured part of cancer treatment.

Medical tech giant Teleflex goes live with o9's AI planning platform, a strategic move to boost resilience and patient care in a post-pandemic world.

The specialty infusion provider is the first to earn a rigorous new distinction, signaling a major leap forward in patient safety and quality of care.

A plant-based gel that stops severe bleeding in seconds is being showcased to top trauma experts, signaling a major shift in emergency medicine.

Aclarion brings its AI-powered diagnostic tool, NOCISCAN, to a top investor summit, aiming to revolutionize chronic back pain treatment. Can it succeed?

A new clinical trial begins for APAC, a first-in-class drug aiming to prevent amputation and death from severe peripheral artery disease.

After a massive divestiture and balance sheet overhaul, Elutia is all-in on its next-gen biomatrix, NXT-41x, to disrupt the $1.5B breast surgery market.

Industry pioneer Lee Leichter joins EdgeOne Medical, a strategic move to master the complex, high-stakes world of combination product regulation.

As AI progress stalls on bad data, a new research lab is bringing scientific discipline to the industry's most overlooked and critical pillar.

A new patent for its iotaSOFT system solidifies iotaMotion's lead in robotic cochlear implants, aiming to tackle a global hearing loss crisis.

After a tense battle with delisting threats, medical technology firm Lifeward has secured its Nasdaq status, clearing the way to refocus on its mission.

A new study validates Noah Medical's robotic bronchoscopy, showing near-perfect accuracy in diagnosing hard-to-reach lung nodules.

As the aesthetics industry booms, a new fractional CFO service aims to solve the growing financial pains and margin crisis facing practice owners.

With a key clinical trial complete, Emboline's new funding aims to commercialize a device designed to make popular heart procedures safer for patients.

Dr. Yulun Wang, inventor of the first FDA-approved surgical robot, joins AiM Medical Robotics, signaling a major leap forward for MRI-guided brain surgery.

With a massive new investment, Vima Therapeutics advances a first-in-class oral drug into Phase 2, offering new hope beyond injections and surgery.

A new study validating patient-reported outcomes in HAE is set to standardize clinical trials, strengthening the case for new oral therapies like deucrictibant.